- European session review: USD mixed as investors assess growing COVID infections, likelihood of more stimulus in U.S.
Notícias do Mercado
European session review: USD mixed as investors assess growing COVID infections, likelihood of more stimulus in U.S.
| Time | Country | Event | Period | Previous value | Forecast | Actual |
|---|---|---|---|---|---|---|
| 07:00 | United Kingdom | Average earnings ex bonuses, 3 m/y | October | 1.9% | 2.6% | 2.8% |
| 07:00 | United Kingdom | Average Earnings, 3m/y | October | 1.4% | 2.2% | 2.7% |
| 07:00 | United Kingdom | ILO Unemployment Rate | October | 4.8% | 5.1% | 4.9% |
| 07:00 | United Kingdom | Claimant count | November | -29.8 | 64.3 | |
| 07:30 | Switzerland | Producer & Import Prices, y/y | November | -2.9% | -2.7% | |
| 07:45 | France | CPI, y/y | November | 0% | 0.2% | 0.2% |
| 07:45 | France | CPI, m/m | November | 0% | 0.2% | 0.2% |
| 09:00 | France | IEA Oil Market Report | ||||
| 13:15 | Canada | Housing Starts | November | 215.1 | 215 | 246 |
USD traded mixed against its major rivals in the European session on Tuesday as investors weighed accelerating COVID-19 cases against prospects for more coronavirus stimulus aid. The U.S. currency rose against EUR, CHF, AUD and NZD, but fell against GBP, JPY and CAD.
The U.S. lawmakers released the latest proposal for a COVID-19 relief bill, splitting a previous $908 billion bipartisan proposal into two bills - one bill for $748 billion that calls for spending for programs that are popular on both sides of the aisle and the second bill for $160 billion that includes the more contentious areas such as state and local aid and liability protection. House Speaker Nancy Pelosi said that both sides remained in negotiations.
According to the latest data by Johns Hopkins, the U.S. topped 300,000 coronavirus deaths on Monday, while the total number of confirmed cases surpassed 16.5 million.
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer